{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:15:12Z","timestamp":1775024112788,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,31]]},"DOI":"10.7759\/cureus.106239","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:15:47Z","timestamp":1775016947000},"source":"Crossref","is-referenced-by-count":0,"title":["WZB117-Induced Glucose Hypometabolism Triggers Mitochondrial Dysfunction and Amyloidogenic Processing in an In Vitro Primary Forebrain Neuron Model"],"prefix":"10.7759","author":[{"given":"Sajidali S","family":"Saiyad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay Prakash S","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep  M","family":"Horo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Komal","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanta","family":"Chatterjee Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gnanadesigan","family":"Ekambaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anju","family":"Chouhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surbhi","family":"Ranga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer's disease","volume":"3","author":"Brookmeyer R","year":"2007","unstructured":"Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007, 3:186-91. 10.1016\/j.jalz.2007.04.381","journal-title":"Alzheimers Dement"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.082867","article-title":"Epidemiology and risk factors of dementia","volume":"76","author":"van der Flier WM","year":"2005","unstructured":"van der Flier WM, Scheltens P. Epidemiology and risk factors of dementia. J Neurol Neurosurg Psychiatry. 2005, 76:v2-7. 10.1136\/jnnp.2005.082867","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak H","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-59. 10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe DJ","year":"2001","unstructured":"Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 2001, 81:741-66. 10.1152\/physrev.2001.81.2.741","journal-title":"Physiol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth HW","year":"2010","unstructured":"Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med. 2010, 362:329-44. 10.1056\/NEJMra0909142","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy J","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002, 297:353-6. 10.1126\/science.1072994","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal K","year":"2010","unstructured":"Iqbal K, Liu F, Gong CX, Grundke-Iqbal I. Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res. 2010, 7:656-64. 10.2174\/156720510793611592","journal-title":"Curr Alzheimer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1991.65","article-title":"Diminished glucose transport in Alzheimer's disease: dynamic PET studies","volume":"11","author":"Jagust WJ","year":"1991","unstructured":"Jagust WJ, Seab JP, Huesman RH, et al.. Diminished glucose transport in Alzheimer's disease: dynamic PET studies. J Cereb Blood Flow Metab. 1991, 11:323-30. 10.1038\/jcbfm.1991.65","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-005-1762-7","article-title":"Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD","volume":"32","author":"Mosconi L","year":"2005","unstructured":"Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging. 2005, 32:486-510. 10.1007\/s00259-005-1762-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2006.12.003","article-title":"Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease","volume":"155","author":"Hunt A","year":"2007","unstructured":"Hunt A, Sch\u00f6nknecht P, Henze M, Seidl U, Haberkorn U, Schr\u00f6der J. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease. Psychiatry Res. 2007, 155:147-54. 10.1016\/j.pscychresns.2006.12.003","journal-title":"Psychiatry Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000328","article-title":"Brain glucose transporters: implications for neurologic disease","volume":"82","author":"Benarroch EE","year":"2014","unstructured":"Benarroch EE. Brain glucose transporters: implications for neurologic disease. Neurology. 2014, 82:1374-9. 10.1212\/WNL.0000000000000328","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1989.tb07399.x","article-title":"Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease","volume":"53","author":"Kalaria RN","year":"1989","unstructured":"Kalaria RN, Harik SI. Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J Neurochem. 1989, 53:1083-8. 10.1111\/j.1471-4159.1989.tb07399.x","journal-title":"J Neurochem"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2007.12.035","article-title":"Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease","volume":"582","author":"Liu Y","year":"2008","unstructured":"Liu Y, Liu F, Iqbal K, Grundke-Iqbal I, Gong CX. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett. 2008, 582:359-64. 10.1016\/j.febslet.2007.12.035","journal-title":"FEBS Lett"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp099","article-title":"Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease","volume":"132","author":"Liu F","year":"2009","unstructured":"Liu F, Shi J, Tanimukai H, et al.. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. Brain. 2009, 132:1820-32. 10.1093\/brain\/awp099","journal-title":"Brain"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer's disease is type 3 diabetes-evidence reviewed","volume":"2","author":"de la Monte SM","year":"2008","unstructured":"de la Monte SM, Wands JR. Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol. 2008, 2:1101-13. 10.1177\/193229680800200619","journal-title":"J Diabetes Sci Technol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2004.02.049","article-title":"Glucose metabolism and insulin receptor signal transduction in Alzheimer disease","volume":"490","author":"Hoyer S","year":"2004","unstructured":"Hoyer S. Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol. 2004, 490:115-25. 10.1016\/j.ejphar.2004.02.049","journal-title":"Eur J Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer's disease: experimental models and reality","volume":"133","author":"Drummond E","year":"2017","unstructured":"Drummond E, Wisniewski T. Alzheimer's disease: experimental models and reality. Acta Neuropathol. 2017, 133:155-75. 10.1007\/s00401-016-1662-x","journal-title":"Acta Neuropathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.030205","article-title":"Neurodegenerative disease: models, mechanisms, and a new hope","volume":"10","author":"Gitler AD","year":"2017","unstructured":"Gitler AD, Dhillon P, Shorter J. Neurodegenerative disease: models, mechanisms, and a new hope. Dis Model Mech. 2017, 10:499-502. 10.1242\/dmm.030205","journal-title":"Dis Model Mech"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0091-679x(03)01004-5","article-title":"The culture of chick forebrain neurons","volume":"71","author":"Heidemann SR","year":"2003","unstructured":"Heidemann SR, Reynolds M, Ngo K, Lamoureux P. The culture of chick forebrain neurons. Methods Cell Biol. 2003, 71:51-65. 10.1016\/s0091-679x(03)01004-5","journal-title":"Methods Cell Biol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2016.02.008","article-title":"Long-term primary culture of neurons taken from chick embryo brain: a model to study neural cell biology, synaptogenesis and its dynamic properties","volume":"263","author":"Kumar A","year":"2016","unstructured":"Kumar A, Mallick BN. Long-term primary culture of neurons taken from chick embryo brain: a model to study neural cell biology, synaptogenesis and its dynamic properties. J Neurosci Methods. 2016, 263:123-33. 10.1016\/j.jneumeth.2016.02.008","journal-title":"J Neurosci Methods"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2010.07.004","article-title":"Mitochondrial dysfunction and Alzheimer's disease","volume":"35","author":"Maruszak A","year":"2011","unstructured":"Maruszak A, \u017bekanowski C. Mitochondrial dysfunction and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35:320-30. 10.1016\/j.pnpbp.2010.07.004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2010.07.021","article-title":"Brain fuel metabolism, aging, and Alzheimer's disease","volume":"27","author":"Cunnane S","year":"2011","unstructured":"Cunnane S, Nugent S, Roy M, et al.. Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition. 2011, 27:3-20. 10.1016\/j.nut.2010.07.021","journal-title":"Nutrition"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.01.006","article-title":"A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease","volume":"11","author":"Newport MT","year":"2015","unstructured":"Newport MT, VanItallie TB, Kashiwaya Y, King MT, Veech RL. A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease. Alzheimers Dement. 2015, 11:99-103. 10.1016\/j.jalz.2014.01.006","journal-title":"Alzheimers Dement"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2015.05.020","article-title":"P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations","volume":"36","author":"Chiu C","year":"2015","unstructured":"Chiu C, Miller MC, Monahan R, Osgood DP, Stopa EG, Silverberg GD. P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations. Neurobiol Aging. 2015, 36:2475-82. 10.1016\/j.neurobiolaging.2015.05.020","journal-title":"Neurobiol Aging"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0692-12.2012","article-title":"Metabolic stress induces BACE1 transcription via NF-\u03baB signaling","volume":"32","author":"Chen Z","year":"2012","unstructured":"Chen Z, Zhong C, Lu W, et al.. Metabolic stress induces BACE1 transcription via NF-\u03baB signaling. J Neurosci. 2012, 32:10352-61. 10.1523\/JNEUROSCI.0692-12.2012","journal-title":"J Neurosci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2350-05.2005","article-title":"Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis","volume":"25","author":"Velliquette RA","year":"2005","unstructured":"Velliquette RA, O'Connor T, Vassar R. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. J Neurosci. 2005, 25:10874-83. 10.1523\/JNEUROSCI.2350-05.2005","journal-title":"J Neurosci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot K","year":"2012","unstructured":"Talbot K, Wang HY, Kazi H, et al.. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012, 122:1316-38. 10.1172\/JCI59903","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield DA","year":"2019","unstructured":"Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019, 20:148-60. 10.1038\/s41583-019-0132-6","journal-title":"Nat Rev Neurosci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2174\/1389450111007011193","article-title":"Multiple defects in energy metabolism in Alzheimer's disease","volume":"11","author":"Ferreira IL","year":"2010","unstructured":"Ferreira IL, Resende R, Ferreiro E, Rego AC, Pereira CF. Multiple defects in energy metabolism in Alzheimer's disease. Curr Drug Targets. 2010, 11:1193-206. 10.2174\/1389450111007011193","journal-title":"Curr Drug Targets"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/474764-wzb117-induced-glucose-hypometabolism-triggers-mitochondrial-dysfunction-and-amyloidogenic-processing-in-an-in-vitro-primary-forebrain-neuron-model","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:15:49Z","timestamp":1775016949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/474764-wzb117-induced-glucose-hypometabolism-triggers-mitochondrial-dysfunction-and-amyloidogenic-processing-in-an-in-vitro-primary-forebrain-neuron-model"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.106239","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,31]]}}}